Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Priority to NZ501664ApriorityCriticalpatent/NZ501664A/en
Priority claimed from PCT/GB1997/001618external-prioritypatent/WO1998057980A1/en
Publication of NZ501664ApublicationCriticalpatent/NZ501664A/en
Peptides and peptide mimetics that bind to the IL-5 receptor. The peptides and peptide mimetics are useful in methods for treating disorders that involve improper production of or response to IL-5 and or the production and accumulation of eosinophils, such as asthma, as well as in diagnostic methods employing labelled peptides and peptide mimetics.
NZ501664A1997-06-161997-06-16Peptides and peptide mimetics that bind to the IL-5 receptor
NZ501664A
(en)